The Acceleration Round is intended to support commercial rollout, regulatory progress, further clinical validation, and ...

Researchers now recognize eight different trajectories after COVID infection; some are severely ill many months later.

EpitogenX and Attomarker sign co-development agreement to advance precision immunology diagnostics in multiple diseases ...

Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of ...

Researchers at Örebro University have identified blood markers that can indicate who is at risk of developing ulcerative ...